![JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study](https://www.mdpi.com/jcm/jcm-09-02308/article_deploy/html/images/jcm-09-02308-g004.png)
JCM | Free Full-Text | Diagnostic Performance of [18F]Fluorocholine and [68Ga]Ga-PSMA PET/CT in Prostate Cancer: A Comparative Study
![Free PSA/Total PSA Ratio Increases the Detection Rate of Prostate Cancer in Twelve-Core Biopsy | Semantic Scholar Free PSA/Total PSA Ratio Increases the Detection Rate of Prostate Cancer in Twelve-Core Biopsy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/40725fdb70910b2c8b501b0068c6e99383f7a36b/2-Table1-1.png)
Free PSA/Total PSA Ratio Increases the Detection Rate of Prostate Cancer in Twelve-Core Biopsy | Semantic Scholar
![Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis](https://www.degruyter.com/document/doi/10.1515/cclm-2020-0145/asset/graphic/j_cclm-2020-0145_fig_002.jpg)
Untangling the association between prostate-specific antigen and diabetes: a systematic review and meta-analysis
![Undetectable PSA Levels Tied to Improvements in rPFS, OS in Metastatic Hormone-Sensitive Prostate Cancer - Oncology Nurse Advisor Undetectable PSA Levels Tied to Improvements in rPFS, OS in Metastatic Hormone-Sensitive Prostate Cancer - Oncology Nurse Advisor](https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2021/05/psatestwebg645186716_1354110-860x573.jpg)
Undetectable PSA Levels Tied to Improvements in rPFS, OS in Metastatic Hormone-Sensitive Prostate Cancer - Oncology Nurse Advisor
ASCO 2022: Phase II, Double-Blind, Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk PSA-Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
![Solitary Testicular Metastasis from Prostate Cancer: A Rare Case of Isolated Recurrence after Radical Prostatectomy | Anticancer Research Solitary Testicular Metastasis from Prostate Cancer: A Rare Case of Isolated Recurrence after Radical Prostatectomy | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/30/5/1747/F4.large.jpg)
Solitary Testicular Metastasis from Prostate Cancer: A Rare Case of Isolated Recurrence after Radical Prostatectomy | Anticancer Research
![performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram](https://www.researchgate.net/publication/10978140/figure/tbl2/AS:601775400820743@1520485844541/performance-of-PSA-density-with-respect-to-multiple-cutoff-levels-Note-the-unacceptable.png)
performance of PSA density with respect to multiple cutoff levels. Note... | Download Scientific Diagram
![Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy](https://www.frontiersin.org/files/Articles/656444/fonc-11-656444-HTML/image_m/fonc-11-656444-t003.jpg)
Frontiers | Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
![Isolated prostate cancer soft tissue recurrence 10 years after radical prostatectomy | BMJ Case Reports Isolated prostate cancer soft tissue recurrence 10 years after radical prostatectomy | BMJ Case Reports](https://casereports.bmj.com/content/casereports/2017/bcr-2017-220140/F3.large.jpg)
Isolated prostate cancer soft tissue recurrence 10 years after radical prostatectomy | BMJ Case Reports
![ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial](https://larvolclin.s3.us-west-2.amazonaws.com/resize_166306090938969400863204badaece6.png)
ESMO 2022: Association between prostate-specific antigen decline and clinical outcomes in patients with metastatic castration-resistant prostate cancer in the VISION trial
![Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study) | Journal of Nuclear Medicine Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study) | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/63/2/240/F1.large.jpg)